Irish Drugmaker Elan To Spin Off R&D Business
Irish pharmaceutical company Elan Corp. PLC will spin off its drug research business platform from the company in order to present a more streamlined and profitable financial picture to its investors...To view the full article, register now.
Already a subscriber? Click here to view full article